Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Aprikos Pharmaceuticals Private Limited, was an unlisted private company incorporated on 21 February, 2012. It is classified as a private limited company and is located in , Delhi. It's authorized share capital was INR 1.00 lac and the total paid-up capital was INR 1.00 lac.
The current status of Aprikos Pharmaceuticals Private Limited is - Strike Off.
Read more
Buy Dashboard using Credits
** All rupee values in INR crores. Based on March 2025 numbers.
-6.49%
-6.6%
190.59%
-7.96%
47.15%
3.46%
0.27
-0.13
7.03
7.53
-2.41
0.18
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
Choose number of credits to buy
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
India
(1)
| State | Type | Address |
|---|---|---|
| Delhi | Registered Office | 16, BUNGLOW ROAD KAMLA NAGAR DELHI North West Delhi - 110007 |
Locations on Map
Filter (4)
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Bhawan Jain | 01278924 | 14 years |
| Director | Krishan Chander | 01775567 | 14 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| TECH SQUARE ENGINEERING PRIVATE LIMITED |
Active
|
2.0 L | 1 | Delhi |
| SPIRITUAL TRADES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| TREE ZONE AGENCIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| APIMJA PHARMACEUTICAL PRIVATE LIMITED |
Active
|
3.0 L | 1 | Delhi |
| ACLON POLY COMPOUNDS PRIVATE LIMITED |
Active
|
30.0 L | 1 | Delhi |
| XOP NETWORKS INDIA PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Delhi |
Severe Risk
Moderate Risk
Low Risk
Read more
The incorporation date of APRIKOS PHARMACEUTICALS PRIVATE LIMITED is 21 February, 2012
The authorized share capital of APRIKOS PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 1.0 L.
The paid-up capital of APRIKOS PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 1.0 L.
The registered address of APRIKOS PHARMACEUTICALS PRIVATE LIMITED is 16, BUNGLOW ROAD KAMLA NAGAR DELHI North West Delhi - 110007
The CIN number of APRIKOS PHARMACEUTICALS PRIVATE LIMITED is U51909DL2012PTC231768.
